1. Home
  2. TRVI vs WABC Comparison

TRVI vs WABC Comparison

Compare TRVI & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • WABC
  • Stock Information
  • Founded
  • TRVI 2011
  • WABC 1972
  • Country
  • TRVI United States
  • WABC United States
  • Employees
  • TRVI N/A
  • WABC N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • WABC Major Banks
  • Sector
  • TRVI Health Care
  • WABC Finance
  • Exchange
  • TRVI Nasdaq
  • WABC Nasdaq
  • Market Cap
  • TRVI 1.4B
  • WABC 1.2B
  • IPO Year
  • TRVI 2019
  • WABC N/A
  • Fundamental
  • Price
  • TRVI $13.34
  • WABC $48.77
  • Analyst Decision
  • TRVI Strong Buy
  • WABC Hold
  • Analyst Count
  • TRVI 11
  • WABC 2
  • Target Price
  • TRVI $20.59
  • WABC $52.00
  • AVG Volume (30 Days)
  • TRVI 1.8M
  • WABC 129.1K
  • Earning Date
  • TRVI 11-13-2025
  • WABC 01-15-2026
  • Dividend Yield
  • TRVI N/A
  • WABC 3.80%
  • EPS Growth
  • TRVI N/A
  • WABC N/A
  • EPS
  • TRVI N/A
  • WABC 4.59
  • Revenue
  • TRVI N/A
  • WABC $264,660,000.00
  • Revenue This Year
  • TRVI N/A
  • WABC N/A
  • Revenue Next Year
  • TRVI N/A
  • WABC N/A
  • P/E Ratio
  • TRVI N/A
  • WABC $10.54
  • Revenue Growth
  • TRVI N/A
  • WABC N/A
  • 52 Week Low
  • TRVI $2.36
  • WABC $42.00
  • 52 Week High
  • TRVI $13.73
  • WABC $58.28
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 72.54
  • WABC 58.28
  • Support Level
  • TRVI $10.46
  • WABC $46.24
  • Resistance Level
  • TRVI $12.14
  • WABC $47.90
  • Average True Range (ATR)
  • TRVI 0.79
  • WABC 1.24
  • MACD
  • TRVI 0.06
  • WABC 0.16
  • Stochastic Oscillator
  • TRVI 92.05
  • WABC 67.06

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About WABC Westamerica Bancorporation

Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.

Share on Social Networks: